Background A safe and effective treatment for melasma, an acquired refractory pigmented
skin disease, remains a problem, although numerous clinical trials have explored the …

Objective Tyrosinase is the rate‐limiting enzyme in melanogenesis. Thiamidol is the most
potent inhibitor of human tyrosinase out of 50 000 tested compounds. In clinical studies, it …

BACKGROUND Melasma is an acquired hyperpigmented skin disorder. Tranexamic acid
(TXA) prevents ultraviolet radiation induced pigmentation in melasma through interfering …

Melasma is a common skin disorder of acquired hyperpigmentation that appears commonly
on the face. Although asymptomatic, melasma causes psychosocial and emotional distress …

Background Melasma is a common, multifactorial, and recurring disease which is not easy to
treat. Aims The purpose of this study is to evaluate the efficacy of microneedling in …

Treatment of melasma by a combination of intense pulsed ligh... : Medicine Treatment of
melasma by a combination of intense pulsed light with advanced optimal pulse technology and …

Background Melasma negatively impacts patient's quality of life (QoL). Although
hydroquinone 4% is the most prescribed treatment, several side effects had been reported …

Introducción: el melasma es una hipermelanosis adquirida, crónica, recurrente y simétrica
que se caracteriza por manchas en áreas expuestas al sol, circunscritas, de color café claro …

Hyperpigmentation is a common concern of patients in aesthetic practice. There are various
treatment options, but topical depigmenting agents such as hydroquinone (HQ) are usually a …

Background: Laser toning is one of the most popular strategies to treat facial
photopigmentation and aging. Several laser modalities, including fractional non-ablative, Q …